Fuminori Hirano

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators

Ralf Dechend, Fuminori Hirano, Kerstin Lehmann et al. · Oncogene · 1999 · 317 citations

Life Sciences, Cell Biology, Molecular Biology +13

Functional Interference of Sp1 and NF-κB through the Same DNA Binding Site

Fuminori Hirano, Hirotoshi Tanaka, Yoshiko Hirano et al. · Molecular and Cellular Biology · 1998 · 157 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids

Fuminori Hirano, Hirotoshi Tanaka, Yuichi Makino et al. · Carcinogenesis · 1996 · 69 citations

Medicine, Molecular Biology, Oncology +14

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients

Kiyoshi Migita, Yukihiro Akeda, Manabu Akazawa et al. · Arthritis Research & Therapy · 2015 · 64 citations · Full text

Medicine, Clinical Sciences, Immunology +14